Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesCytokine, sickness behavior, and depressionIndoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's DiseaseRole of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesityAlcoholism and inflammation: neuroimmunology of behavioral and mood disordersInduction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behaviorInflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood.Stress and depression: preclinical research and clinical implicationsInterferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-GuerinCognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome.Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice culturesInflammation-associated depression: from serotonin to kynurenineImmunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.Controversies about a common etiology for eating and mood disorders.Human sickness behavior: Ultimate and proximate explanations.Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide.Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing.Immune system to brain signaling: neuropsychopharmacological implications.Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice.Neuropeptides and the microbiota-gut-brain axisAmino acid catabolism: a pivotal regulator of innate and adaptive immunity.The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.From head to tail it's a 2 way street for neuro-immune communicationIndoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge.Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.The possible role of the kynurenine pathway in anhedonia in adolescents.Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin.Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice.Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studiesImmunomodulatory Factors Galectin-9 and Interferon-Gamma Synergize to Induce Expression of Rate-Limiting Enzymes of the Kynurenine Pathway in the Mouse Hippocampus.Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.A critical review of human endotoxin administration as an experimental paradigm of depression.Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice.
P2860
Q21129356-88F49253-2674-409F-96D4-838ADD1F1A4CQ24657818-5C2DF634-BF86-4728-8D5B-380D09BE725BQ26781849-62CB0CD0-E185-463E-B056-FDDB1E6254F8Q26802171-AF46B236-65DD-42A8-BEFA-AAFF8B2F13B5Q28302013-22C77430-7B49-45BA-85FB-7E4826E3DEEAQ28508390-33BFD6FC-5BEA-4A69-8611-27CFD67B4CFCQ30430203-0F3AAF48-2F0D-4FDC-A0DB-9A8E8A66A56CQ33404098-5A88AF77-6639-4FAF-9B2F-627C404D9672Q33715452-A0EA1742-5F4F-477D-ADEE-1C36B23FCD8AQ34031315-C96ADF0A-C183-43A5-B677-F2628E255B6AQ34051382-325373DB-4E05-4735-A683-8FAE48D75B84Q34064890-BE1157CF-EFC5-4126-9AA9-CEC91543FD62Q34147377-E102C033-4BC3-4244-A071-45E11B2D9E9FQ34213029-5E7E903B-1F47-4E8D-A70B-9D203D7ED407Q34369407-8DC359FF-A42E-482E-B70E-ECCD76C0C926Q34406540-1DACB49B-F878-494D-A9C0-3F59766D87CFQ34460763-313122CE-2D9B-419B-8B75-B810BD817101Q34499830-2E12DB4E-AB57-49DB-9124-910E3E866113Q34574428-1570F88B-FEEA-4A4B-950E-FAAAACC68E87Q34769827-C025BAF2-1092-439E-A6CC-1B039BAB7377Q35006487-EB333B18-5FF1-484D-82C3-E0D84E285EDDQ35178233-26A94332-9565-4E3C-BE39-B2597C8F24D9Q35261125-63FC0C1D-5FE9-4FBB-8D44-69E219E1227DQ35602606-CDBF9350-D362-4AE5-815D-5DD9CA6EBA77Q35951167-F974F5A6-40A8-421C-AF83-4311782D3573Q36052673-91506F8C-4A1C-462F-B290-FD32A9D8D024Q36106605-537DD086-AB8B-4503-AF7E-89C9BF114756Q36183347-86D6CC55-E2EB-459D-B4B6-C49ADBBB8FB1Q36451817-2E950B1A-0023-4C13-878E-B959454E62DFQ36865674-9B02C5FA-A8BB-4B0F-B10F-8A8929E5D81DQ36921329-D73E9C70-1DC0-46F6-B128-6E026D2CCD6AQ36941359-9AE8B80D-1C64-4F39-A008-BFAFC330E424Q36945216-5002FC34-1372-4EEE-B4EB-45E254C075BEQ37030206-3F7614C4-F778-4A9C-9F40-95E5B605E69FQ37082976-8CF6EE93-A88F-4C74-9457-2E411430D82EQ37114639-152F42A5-81D1-47E6-96F5-3E4A87E67EC5Q37342523-B2F35B19-3ABA-4E5F-BCEF-BFF3AFEBCA9AQ37352554-EFBE3BCC-C6A9-4322-95F4-315EC1BD93AEQ37481759-C984FEF3-0753-4B8A-AAD4-A0C9713BD7E4Q37630370-6BB064B0-B55F-4171-8036-0879D10CC821
P2860
Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@ast
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@en
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@nl
type
label
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@ast
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@en
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@nl
prefLabel
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@ast
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@en
Inoculation of Bacillus Calmet ...... onic depressive-like behavior.
@nl
P2093
P2860
P50
P1476
Inoculation of Bacillus Calmet ...... ronic depressive-like behavior
@en
P2093
Caroline André
Jacques Lestage
Jason C O'Connor
Jeffrey A Woods
Maïté Moreau
Sara A Dumich
P2860
P304
P356
10.1016/J.BBI.2008.04.001
P577
2008-05-13T00:00:00Z